Skip to main content
. 2023 Jan 30;15(1):e34395. doi: 10.7759/cureus.34395

Table 5. WHO severity score of the pregnant COVID-19 women pre-tocilizumab and followed up on days 2, 5, 10, 30, and 60.

COVID-19: coronavirus disease 2019

WHO severity scale Admission Pre-tocilizumab  Post-tocilizumab administration day
Day 2 Day 5 Day 10 Day 30 Day 60
1 - - - - 1 24 25
2 - - - - 11 - -
3 1 - - - - - -
4 3 - - 8 5 - -
5 24 - 1 8 3 - -
6 - 28 27 12 8 1 -
7 - - - - - - -
8 - - - - - 2 1
9 - - - - - - -
10 - - - - - 1 2